Literature DB >> 629275

Irreversibly sickled cells and red cell survival in sickle cell anemia: a study with both DF32P and 51CR.

P R McCurdy, A S Sherman.   

Abstract

For 25 subjects with sickle cell anemia the mean red cell life span measured with Di-isopropylfluorophosphite-32P (DF32P) was 17.32 +/- 4.51 days. Performed simultaneously, the half life (T1/2 of radioactively-labelled chromium 51Cr) was 10.11 +/- 2.82 days (14 subjects). Eight additional subjects, or more than 30 per cent of those studied using both red cell tags, had 51Cr red cell survival curves better described by two exponents than by one, apparently due to two different rates of 51Cr elution from the red cells. This finding limits the value of quantitative data obtained by this procedure. A negative correlation was found between the mean red cell life span measured with DF32P-tagged cells and the proportion of irreversibly sickled cells in venous or capillary blood. A similar negative correlation was found between the red cell half survival time measured with 51Cr-tagged cells and the proportion of irreversibly sickled cells. These data are compatible with the view that repeated sickling and, in particular, the formation of irreversibly sickled cells play a distinct role in the pathogenesis of hemolysis in sickle cell anemia.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 629275     DOI: 10.1016/0002-9343(78)90053-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  17 in total

1.  Hemoglobin sickle cell disease complications: a clinical study of 179 cases.

Authors:  François Lionnet; Nadjib Hammoudi; Katia Stankovic Stojanovic; Virginie Avellino; Gilles Grateau; Robert Girot; Jean-Philippe Haymann
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

2.  Cation depletion by the sodium pump in red cells with pathologic cation leaks. Sickle cells and xerocytes.

Authors:  C H Joiner; O S Platt; S E Lux
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

Review 3.  Hb F in sickle cell anemia.

Authors:  A D Adekile; T H Huisman
Journal:  Experientia       Date:  1993-01-15

Review 4.  Sickle cell states and the anaesthetist.

Authors:  D W Esseltine; M R Baxter; J C Bevan
Journal:  Can J Anaesth       Date:  1988-07       Impact factor: 5.063

5.  Heinz bodies induce clustering of band 3, glycophorin, and ankyrin in sickle cell erythrocytes.

Authors:  S M Waugh; B M Willardson; R Kannan; R J Labotka; P S Low
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

6.  Sickle erythrocyte adherence to vascular endothelium. Morphologic correlates and the requirement for divalent cations and collagen-binding plasma proteins.

Authors:  N Mohandas; E Evans
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

Review 7.  Knowledge insufficient: the management of haemoglobin SC disease.

Authors:  Lydia H Pecker; Beverly A Schaefer; Lori Luchtman-Jones
Journal:  Br J Haematol       Date:  2016-12-16       Impact factor: 6.998

8.  Evidence for ineffective erythropoiesis in severe sickle cell disease.

Authors:  Catherine J Wu; Lakshamanan Krishnamurti; Jeffery L Kutok; Melinda Biernacki; Shelby Rogers; Wandi Zhang; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2005-08-09       Impact factor: 22.113

9.  The distribution of copper in sickling erythrocytes as determined by an IBM cell separator.

Authors:  K Schaeffer; J Aikens; M Williamson; E J Olson
Journal:  J Natl Med Assoc       Date:  1981       Impact factor: 1.798

10.  Mathematical analysis of 51Cr-labelled red cell survival curves in congenital haemolytic anaemias.

Authors:  A G Kasfiki; S E Antipas; P A Dimitriou; F A Gritzali; K G Melissinos
Journal:  Eur J Nucl Med       Date:  1982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.